Albuterol Sulfate
Brand name: Albuterol Sulfate Hfa
Rank #56 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$312.2M
Total Cost
7,904,120
Total Claims
$312.2M
Total Cost
147,732
Prescribers
$39
Cost per Claim
2,895,345
Beneficiaries
9,495,683
30-Day Fills
$2,113
Avg Cost/Provider
54
Avg Claims/Provider
Share of Medicare Part D Spending
0.11%
of total Medicare Part D spending
$312.2M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $312.2M total
Top Prescribers of Albuterol Sulfate
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Jorge Sanchez-Masiques | Pulmonary Disease | Miami, FL | 17,443 | $597K |
| 2 | Armando Cardona-Ramirez | Pulmonary Disease | Mayaguez, PR | 2,374 | $110K |
| 3 | Juan Candelario Lanza | Pulmonary Disease | Caguas, PR | 2,197 | $102K |
| 4 | Domingo Chardon | Pulmonary Disease | Ponce, PR | 2,138 | $100K |
| 5 | Carissa Cruz Berrios | Internal Medicine | Humacao, PR | 2,048 | $95K |
| 6 | Juan Rodriguez | Pulmonary Disease | Pembroke Pines, FL | 1,255 | $89K |
| 7 | Yoel Brito | Pulmonary Disease | Miami, FL | 2,206 | $84K |
| 8 | Jorge Sanchez-Masiques | Pulmonary Disease | Miami, FL | 1,352 | $80K |
| 9 | Luis Velez-Quinones | Internal Medicine | Arecibo, PR | 1,870 | $76K |
| 10 | Richard Deluca | Pulmonary Disease | Bronx, NY | 1,043 | $68K |
| 11 | Odette Campbell | Internal Medicine | Plano, TX | 609 | $68K |
| 12 | Chitra Kandaswamy | Pulmonary Disease | Fresno, CA | 1,968 | $68K |
| 13 | Najmuddin Karimjee | Internal Medicine | Houston, TX | 1,772 | $68K |
| 14 | Edgardo Cartagena Ayala | Pulmonary Disease | San Juan, PR | 1,580 | $67K |
| 15 | Sergio Martinez | Pulmonary Disease | Jackson Heights, NY | 1,861 | $66K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 53 | Abiraterone Acetate (Abiraterone Acetate) | $345.0M | 122,643 |
| 54 | Icosapent Ethyl (Vascepa) | $334.9M | 692,252 |
| 55 | Cariprazine Hcl (Vraylar) | $329.1M | 226,854 |
| 56 | Albuterol Sulfate (Albuterol Sulfate Hfa) | $312.2M | 7,904,120 |
| 57 | Rifaximin (Xifaxan) | $310.0M | 111,328 |
| 58 | Sitagliptin Phos/Metformin Hcl (Janumet) | $302.2M | 329,315 |
| 59 | Tofacitinib Citrate (Xeljanz Xr) | $294.4M | 49,478 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology